Article Details

Tryptamine Therapeutics launches on ASX with innovative psilocin formulation

Retrieved on: 2024-05-30 16:04:32

Tags for this article:

Click the tags to see associated articles and topics

Tryptamine Therapeutics launches on ASX with innovative psilocin formulation. View article details on hiswai:

Excerpt

(ASX: TYP) CEO Jason Carroll sits down with Jonathan Jackson in the proactive studio to talk about the start of trading on the Australian Securities ...

Article found on: www.investorsobserver.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up